Concepedia

Zhujun Cao

ZC

Statistics

Publications

37

Citations

2.3K

H-Index

21

Active since

2015

Affiliations

Ruijin Hospital(Current)

Shanghai Jiao Tong University

The University of Sydney

Soochow University

Robert Bosch (Australia)

Zhujun Cao is an author at Ruijin Hospital specializing in liver disease, hepatology, and medicine.

ORCID

Publications per year

2015–2024

37

Publications

37

Hydroxychloroquine in patients with mainly mild to moderate coronavirus disease 2019: open label, randomised controlled trial

Wei Tang, Zhujun Cao, Mingfeng Han et al. · BMJ · 2020 · 1.1K citations · Full text

, , +10

VV116 versus Nirmatrelvir–Ritonavir for Oral Treatment of Covid-19

Zhujun Cao, Weiyi Gao, Hong Bao et al. · New England Journal of Medicine · 2022 · 228 citations · Full text

, , +16

Hydroxychloroquine in patients mainly with mild to moderate COVID–19: an open–label, randomized, controlled trial

Wei Tang, Zhujun Cao, Mingfeng Han et al. · medRxiv · 2020 · 198 citations · Full text

, , +12

Enhanced autophagy contributes to protective effects of IL-22 against acetaminophen-induced liver injury

Ruidong Mo, Rongtao Lai, Jie Lu et al. · Theranostics · 2018 · 64 citations · Full text

, , +17

The Use of NACSELD and EASL-CLIF Classification Systems of ACLF in the Prediction of Prognosis in Hospitalized Patients With Cirrhosis

Zhujun Cao, Yuhan Liu, Minghao Cai et al. · The American Journal of Gastroenterology · 2020 · 58 citations

, , +17

1–5 of 37